MA51730A - Fumarate de diméthyle et régimes de vaccination - Google Patents
Fumarate de diméthyle et régimes de vaccinationInfo
- Publication number
- MA51730A MA51730A MA051730A MA51730A MA51730A MA 51730 A MA51730 A MA 51730A MA 051730 A MA051730 A MA 051730A MA 51730 A MA51730 A MA 51730A MA 51730 A MA51730 A MA 51730A
- Authority
- MA
- Morocco
- Prior art keywords
- dimethyl fumarate
- immunization regimes
- regimes
- immunization
- fumarate
- Prior art date
Links
- LDCRTTXIJACKKU-ONEGZZNKSA-N dimethyl fumarate Chemical compound COC(=O)\C=C\C(=O)OC LDCRTTXIJACKKU-ONEGZZNKSA-N 0.000 title 1
- 229960004419 dimethyl fumarate Drugs 0.000 title 1
- 230000003053 immunization Effects 0.000 title 1
- 238000002649 immunization Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461953259P | 2014-03-14 | 2014-03-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA51730A true MA51730A (fr) | 2020-12-16 |
Family
ID=52737422
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA051730A MA51730A (fr) | 2014-03-14 | 2015-03-13 | Fumarate de diméthyle et régimes de vaccination |
| MA039743A MA39743A (fr) | 2014-03-14 | 2015-03-13 | Fumarate de diméthyle et régimes de vaccination |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA039743A MA39743A (fr) | 2014-03-14 | 2015-03-13 | Fumarate de diméthyle et régimes de vaccination |
Country Status (6)
| Country | Link |
|---|---|
| US (5) | US10391160B2 (fr) |
| EP (2) | EP3650042A1 (fr) |
| CA (1) | CA2942690A1 (fr) |
| MA (2) | MA51730A (fr) |
| MX (2) | MX389474B (fr) |
| WO (1) | WO2015138917A1 (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3650042A1 (fr) | 2014-03-14 | 2020-05-13 | Biogen MA Inc. | Fumarate de diméthyle et régimes de vaccination |
| MA40985A (fr) | 2014-11-17 | 2017-09-26 | Biogen Ma Inc | Méthodes de traitement de la sclérose en plaques |
| EP3250198A1 (fr) * | 2014-12-04 | 2017-12-06 | Biogen MA Inc. | Régime de traitement de la sclérose en plaques utilisant du fumarate de diméthyle |
| CA3182369A1 (fr) * | 2020-05-06 | 2021-07-22 | Imcyse Sa | Polytherapie pour le traitement de maladies associees au fumarate |
| CN117320710A (zh) * | 2020-05-06 | 2023-12-29 | 易姆赛斯股份公司 | 用于富马酸酯相关疾病的组合治疗 |
| US20230233500A1 (en) * | 2020-06-11 | 2023-07-27 | University Of Massachusetts | Gasdermin D (GSDMD) Succination for the Treatment of Inflammatory Disease |
| CN117337192A (zh) * | 2021-03-25 | 2024-01-02 | 加州大学董事会 | 用于抑制和治疗病毒感染的组合物和方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19853487A1 (de) | 1998-11-19 | 2000-05-25 | Fumapharm Ag Muri | Verwendung von Dialkylfumaraten |
| PL2316430T3 (pl) | 2004-10-08 | 2012-11-30 | Forward Pharma As | Kompozycje farmaceutyczne o kontrolowanym uwalnianiu, zawierające ester kwasu fumarowego |
| CN114146081A (zh) | 2012-02-07 | 2022-03-08 | 比奥根玛公司 | 含有富马酸二甲酯的药物组合物 |
| US10098863B2 (en) | 2014-02-28 | 2018-10-16 | Banner Life Sciences Llc | Fumarate esters |
| US9326947B1 (en) | 2014-02-28 | 2016-05-03 | Banner Life Sciences Llc | Controlled release fumarate esters |
| US9636318B2 (en) | 2015-08-31 | 2017-05-02 | Banner Life Sciences Llc | Fumarate ester dosage forms |
| ES2713157T3 (es) | 2014-02-28 | 2019-05-20 | Banner Life Sciences Llc | Cápsulas blandas entéricas de liberación controlada de ésteres de fumarato |
| EP3650042A1 (fr) | 2014-03-14 | 2020-05-13 | Biogen MA Inc. | Fumarate de diméthyle et régimes de vaccination |
| AU2015328676B2 (en) | 2014-10-08 | 2017-07-20 | Banner Life Sciences Llc | Controlled release enteric soft capsules of fumarate esters |
| MA40985A (fr) | 2014-11-17 | 2017-09-26 | Biogen Ma Inc | Méthodes de traitement de la sclérose en plaques |
| WO2017040272A1 (fr) | 2015-08-31 | 2017-03-09 | Banner Life Sciences Llc | Formes posologiques d'ester de fumarate |
| WO2017151184A1 (fr) | 2016-02-29 | 2017-09-08 | Banner Life Sciences Llc | Formes posologiques d'ester de fumarate |
| US10523918B2 (en) | 2017-03-24 | 2019-12-31 | Samsung Electronics Co., Ltd. | System and method for depth map |
-
2015
- 2015-03-13 EP EP19199534.9A patent/EP3650042A1/fr not_active Withdrawn
- 2015-03-13 MA MA051730A patent/MA51730A/fr unknown
- 2015-03-13 MX MX2016012052A patent/MX389474B/es unknown
- 2015-03-13 US US15/125,612 patent/US10391160B2/en active Active
- 2015-03-13 CA CA2942690A patent/CA2942690A1/fr active Pending
- 2015-03-13 WO PCT/US2015/020470 patent/WO2015138917A1/fr not_active Ceased
- 2015-03-13 EP EP15712240.9A patent/EP3116536A1/fr not_active Ceased
- 2015-03-13 MA MA039743A patent/MA39743A/fr unknown
-
2016
- 2016-09-14 MX MX2022000746A patent/MX2022000746A/es unknown
-
2019
- 2019-04-23 US US16/391,583 patent/US10555993B2/en not_active Expired - Fee Related
- 2019-12-30 US US16/729,710 patent/US10994003B2/en not_active Expired - Fee Related
-
2021
- 2021-04-12 US US17/228,004 patent/US20210228701A1/en not_active Abandoned
- 2021-11-17 US US17/528,844 patent/US20220072117A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20200360501A1 (en) | 2020-11-19 |
| US10994003B2 (en) | 2021-05-04 |
| CA2942690A1 (fr) | 2015-09-17 |
| US20210228701A1 (en) | 2021-07-29 |
| EP3116536A1 (fr) | 2017-01-18 |
| MX2022000746A (es) | 2022-02-14 |
| MX389474B (es) | 2025-03-20 |
| WO2015138917A1 (fr) | 2015-09-17 |
| US20190247485A1 (en) | 2019-08-15 |
| MX2016012052A (es) | 2017-04-27 |
| US20220072117A1 (en) | 2022-03-10 |
| EP3650042A1 (fr) | 2020-05-13 |
| US20170000873A1 (en) | 2017-01-05 |
| US10555993B2 (en) | 2020-02-11 |
| MA39743A (fr) | 2017-01-18 |
| US10391160B2 (en) | 2019-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL284348A (en) | Hiv pre-immunization and immunotherapy | |
| LT3333191T (lt) | Anti-c10orf54 antikūnai ir jų panaudojimas | |
| BR112016016379A2 (pt) | Implante embólico macio | |
| GB201410971D0 (en) | Vaccine | |
| DK3116911T3 (da) | Anti-mcam-antistoffer og tilhørende fremgangsmåder til anvendelse | |
| DK3169703T3 (da) | Kimær antigenreceptor og anvendelse deraf | |
| HUE040440T2 (hu) | Terápiás HPV16-oltóanyagok | |
| DK3233903T3 (da) | Kimære antigenreceptorer og anvendelsesfremgangsmåder | |
| IL259743B (en) | Bioreactor apparatus and methods | |
| DE202014010318U8 (de) | Wärmebehandlungsvorrichtung | |
| MA51730A (fr) | Fumarate de diméthyle et régimes de vaccination | |
| FI20146023A7 (fi) | Hammas- ja kielituki | |
| EP3879472C0 (fr) | Comparaison et simulation de lavages pour nep | |
| EP3224983C0 (fr) | Procédé et dispositif d'authentification | |
| EP3962112C0 (fr) | Appareil | |
| HUE054052T2 (hu) | Felhasználói készülék és eljárás | |
| LT3122378T (lt) | Mutantų stafilokokiniai antigenai | |
| IL247159B (en) | Components of pcsk9 | |
| NL301350I2 (nl) | tegomilfumaraat | |
| DE112015001144A5 (de) | Therapievorrichtung | |
| LT3188755T (lt) | Vakcina | |
| EP3161483A4 (fr) | Système de test d'immunisation au point d'intervention - méthodes de détection | |
| GB201700309D0 (en) | Scanning device | |
| FR3031032B1 (fr) | Appareil de preparation culinaire | |
| FR3031029B1 (fr) | Appareil de preparation culinaire |